Find out more about Roy Kong's experience
Roy Kong's highlights
FEATURED Conference Proceedings
Oral delivery of the anti-fibrotic, FT011, achieves safe and robust intraocular levels of exposure in subjects undergoing glaucoma filtration surgery
Read moreRoy Kong's selected work
2019-CT-PC-06
Research Contracts
OCX063, a novel small molecule drug, is protective against inflammatory, fibrotic and angi..
Conference Proceedings
Comparison of the in vitro efficacy of OCX063 with Tranilast in RPE cells
Research Contracts
Oral administration of the novel small molecule drug OCX063 protects against inflammation ..
Conference Proceedings
Activity of OccuRx compounds in vitro and in vivo
Research Contracts
OCX063, A Novel Small Molecule Drug, Exhibits Anti-Inflammatory and Anti-Fibrotic Properti..
Conference Proceedings
Roy Kong's selected work
Projects
Displaying the 5 most recent projects by Roy Kong.
Project Types
5
Research Contracts
Scholarly Works
Displaying the 10 most recent scholarly works by Roy Kong.
Honours, Awards and Fellowships
Harold Mitchell Foundation Travel Fellowship
Melbourne Abroad Travelling Scholarship
Florey Student Top-up Scholarship
Melbourne International Research Scholarship
Melbourne International Fee Remission Scholarship
Credentials
Positions
Research Fellow
Medicine - St Vincent's Hospital
Member
Ausbiotech
Member
Association for Research in Vision and Ophthalmology
Member
The Australasian Society of Clincal and Experimental Pharmacologists and Toxicologists
Education
Doctor of Philosophy
University of Melbourne
Bachelor of Science (Degree with Honours)
University of Melbourne
Bachelor of Science
University of Melbourne